These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31325552)

  • 1. Comorbid diseases of vitiligo: A 10-year cross-sectional retrospective study of an urban US population.
    Hadi A; Wang JF; Uppal P; Penn LA; Elbuluk N
    J Am Acad Dermatol; 2020 Mar; 82(3):628-633. PubMed ID: 31325552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
    Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities associated with vitiligo: a ten-year retrospective study.
    Sheth VM; Guo Y; Qureshi AA
    Dermatology; 2013; 227(4):311-5. PubMed ID: 24107643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo and associated autoimmune disease: retrospective review of 300 patients.
    Sawicki J; Siddha S; Rosen C
    J Cutan Med Surg; 2012; 16(4):261-6. PubMed ID: 22784519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
    Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and estimated population burden of selected autoimmune diseases in the United States.
    Jacobson DL; Gange SJ; Rose NR; Graham NM
    Clin Immunol Immunopathol; 1997 Sep; 84(3):223-43. PubMed ID: 9281381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases.
    Amerio P; Di Rollo D; Carbone A; Auriemma M; Marra ME; De Remigis P; Feliciani C; Tracanna M; Tulli A
    Eur J Dermatol; 2010; 20(3):354-8. PubMed ID: 20395193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune diseases in a Nigerian woman--a case report.
    Talabi OA; Owolabi MO; Osotimehin BO
    West Afr J Med; 2003 Dec; 22(4):361-3. PubMed ID: 15008310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities in vitiligo: comprehensive review.
    Dahir AM; Thomsen SF
    Int J Dermatol; 2018 Oct; 57(10):1157-1164. PubMed ID: 29808541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of comorbid rheumatic disorders in vitiligo patients: A nationwide population-based study.
    Choi CW; Eun SH; Choi KH; Bae JM
    J Dermatol; 2017 Aug; 44(8):909-913. PubMed ID: 28370282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population.
    Nejad SB; Qadim HH; Nazeman L; Fadaii R; Goldust M
    Pak J Biol Sci; 2013 Jun; 16(12):570-4. PubMed ID: 24494526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of chronic urticaria with atopic and autoimmune comorbidities: a nationwide population-based study.
    Chiu HY; Muo CH; Sung FC
    Int J Dermatol; 2018 Jul; 57(7):822-829. PubMed ID: 29663342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort.
    Shi J; Huan X; Zhou L; Xi J; Song J; Wang Y; Luo S; Zhao C
    Front Neurol; 2021; 12():790941. PubMed ID: 34880829
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitiligo in multiple autoimmune syndrome: a retrospective study of 11 cases and a review of the literature].
    Klisnick A; Schmidt J; Dupond JL; Bouchou K; Rousset H; Thieblot P; Humbert P; Vidal E; Aumaître O
    Rev Med Interne; 1998 May; 19(5):348-52. PubMed ID: 9775171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea.
    Kang H; Lee S
    Clin Exp Dermatol; 2023 Apr; 48(5):484-489. PubMed ID: 36656897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis.
    Prahalad S; Shear ES; Thompson SD; Giannini EH; Glass DN
    Arthritis Rheum; 2002 Jul; 46(7):1851-6. PubMed ID: 12124869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune disease in families with multiple sclerosis: a population-based study.
    Ramagopalan SV; Dyment DA; Valdar W; Herrera BM; Criscuoli M; Yee IM; Sadovnick AD; Ebers GC;
    Lancet Neurol; 2007 Jul; 6(7):604-10. PubMed ID: 17560172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo: a part of a systemic autoimmune process.
    Gopal KV; Rama Rao GR; Kumar YH; Appa Rao MV; Vasudev P;
    Indian J Dermatol Venereol Leprol; 2007; 73(3):162-5. PubMed ID: 17558047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevalence of autoimmune endocrine diseases in vitiligo patients].
    Troshina EA; Volnukhin VA; Petrov VA; Nuralieva NF; Yukina MY; Orlova EM; Frigo NV
    Ter Arkh; 2020 Nov; 92(10):88-96. PubMed ID: 33346485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus and associated comorbidities: a cross-sectional study.
    Heelan K; Mahar AL; Walsh S; Shear NH
    Clin Exp Dermatol; 2015 Aug; 40(6):593-9. PubMed ID: 25786337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.